サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631553

生体補綴の市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2025年～2030年

Bioprosthetics Market Size, Share & Trends Analysis Report By Product (Allograft, Xenograft), By Application (Cardiovascular, Plastic Surgery & Wound Healing), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 80 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
生体補綴の市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月16日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生体補綴市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の生体人工器官市場規模は2025～2030年にかけてCAGR 4.40％を記録し、2030年までに76億4,000万米ドルに達すると予測されています。

心血管疾患の高い有病率につながるライフスタイルに関連した習慣の前例のない上方シフトは、心臓障害や組織損傷を発症しやすい高齢者の増加と相まって、予測期間中の生体補綴市場の需要を促進すると推定されています。

合成材料ベースの人工関節が示す生体適合性、審美性、強度の低さは、生体人工関節を取り入れることの明白な必要性を示しています。その結果、組織工学的な自家、同種、異種移植製品に対するニーズの高まりが、市場に有利な成長機会をもたらすと予想されます。

この技術では、バルーン血管形成術や冠動脈ステントなどの様々な機器や、心臓外科やインターベンショナルカーディオロジーなどの医療セグメントから借用した幅広い技術が統合され、経カテーテル弁置換術に画期的な飛躍をもたらします。さらに、心臓エコー検査、血管造影、MRI、CTなどの非侵襲的画像診断技術の組み合わせがますます採用されるようになっており、これにより外科医は装置と患者の解剖学的構造の両方を視覚化できるため、開心術を実施する必要がなくなります。

生体補綴市場レポートハイライト

  • 同種移植片セグメントは、予測期間中にCAGRの大幅な成長が見込まれます。これは、手術時間の短縮、切開創の縮小、生理学的受容性の向上、より大きな移植片の入手可能性、麻酔下での合併症のリスクが高い合成移植片を使用する手術の安全な代替手段など、関連する以下の利点の結果です。
  • 形成外科と創傷治癒セグメントは、予測期間中、アプリケーションセグメントで9.6％以上のCAGRを記録すると予測されています。この大きなシェアは、ヘルニアや腹壁再建などの軟部組織修復術の増加に起因しています。
  • さらに、NCBIが発表した調査によると、症例の複雑性が増すにつれて、上記の手技を行う際に集学的アプローチを適用する必要性が高まり、慢性的な障害に関連する罹患率を減少させるためにこれらの生体補綴メッシュの使用が増加しています。
  • 2023年には、欧州が生体補綴市場全体を支配しました。さらに、頻繁な製品承認、高齢者基盤の増加、ライフスタイルに関連した変化、生体補綴ソリューションの利用可能性に関連する高い意識レベルなどの人口統計動向のその後の変化が、この地域の市場成長を促進すると予測されています。
  • 例えば、2016年4月、St. Jude Medical, Inc.は、大動脈弁置換術を必要とする患者に強化された選択肢を提供するTrifecta Surgical Valveの欧州での発売を発表しました。この発売により、欧州におけるSt. Jude Medical, Inc.の既存製品ポートフォリオが拡大しました。
  • この産業の大手企業には、Edwards Lifesciences Corporation、St.Jude Medical, Inc.、Sorin Group、CryoLife, Inc.、Braile Biomedica, Inc.、Medtronic Plcなどがあります。これらの企業は、事業拡大を促進するために、共同戦略の採用や頻繁な製品承認の発表にますます関与しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 生体補綴市場の変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 生体補綴市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 生体補綴市場： 製品別、推定・動向分析

  • セグメントダッシュボード
  • 生体補綴市場：製品変動分析、2023年と2030年
  • 同種移植
  • 異種移植

第5章 生体補綴市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • 生体補綴市場：用途変動分析、2023年と2030年
  • 心臓血管
  • 形成外科と創傷治癒

第6章 生体補綴市場：地域別、推定・動向分析

  • 生体補綴市場シェア、地域別、2023年と2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • LeMaitre Vascular, Inc.
    • Braile Biomedica
    • Labcor Laboratorios Ltda
    • Medtronic
    • Rua Life Sciences Plc（Aortech International Plc.）
    • LivaNova PLC（Sorin Group）
    • Organogenesis Inc.
    • Humacyte Global, Inc.
    • Johnson & Johnson（Ethicon, Inc.）
    • Artivion, Inc.（CryoLife, Inc.）
    • Abbott（St. Jude Medical, Inc.）
    • Edwards Lifesciences Corporation
    • JenaValve
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Bioprosthetics Market, By Product, 2018 - 2030 (USD Million)
  • Table 4. Global Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 5. Global Bioprosthetics Market, By Region, 2018 - 2030 (USD Million)
  • Table 6. North America Bioprosthetics Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America Bioprosthetics Market, By Product, 2018 - 2030 (USD Million)
  • Table 8. North America Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 9. U.S. Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 10. U.S. Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 11. Canada Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 12. Canada Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 13. Mexico Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 14. Mexico Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 15. Europe Bioprosthetics Market, by Country, 2018 - 2030 (USD Million)
  • Table 16. Europe Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 17. Europe Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 18. UK. Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 19. UK Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 20. Germany Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 21. Germany Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 22. France Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 23. France Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 24. Italy Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 25. Italy Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 26. Spain Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 27. Spain Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 28. Denmark Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 29. Denmark Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 30. Sweden Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 31. Sweden Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 32. Norway Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 33. Norway Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Bioprosthetics Market, by Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 37. Japan Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 38. Japan Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 39. China Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 40. China Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 41. India Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 42. India Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 43. Australia Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 44. Australia Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 45. Thailand Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 46. Thailand Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 47. South Korea Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 48. South Korea Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 49. Latin America Bioprosthetics Market, by Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 51. Latin America Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 52. Brazil Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 53. Brazil Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 54. Argentina Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 55. Argentina Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Bioprosthetics Market, by Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 59. South Africa Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 60. South Africa Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 63. UAE Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 64. UAE Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Bioprosthetics market: outlook
  • Fig. 9 Bioprosthetics competitive insights
  • Fig. 10 Ancillary market outlook
  • Fig. 11 Bioprosthetics market driver impact
  • Fig. 12 Bioprosthetics market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Bioprosthetics market: Product movement analysis
  • Fig. 16 Bioprosthetics market: Product outlook and key takeaways
  • Fig. 17 Allograft market estimates and forecast, 2018 - 2030
  • Fig. 18 Xenograft market estimates and forecast, 2018 - 2030
  • Fig. 19 Bioprosthetics market: Application movement analysis
  • Fig. 20 Bioprosthetics market: Application outlook and key takeaways
  • Fig. 21 Cardiovascular market estimates and forecasts, 2018 - 2030
  • Fig. 22 Plastic surgery & wound healing market estimates and forecasts, 2018 - 2030
  • Fig. 23 Global bronchoscopes market: Regional movement analysis
  • Fig. 24 Global bronchoscopes market: Regional outlook and key takeaways
  • Fig. 25 North America bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Key country dynamics
  • Fig. 27 U.S. bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 Canada bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Mexico bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 UK bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Germany bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Spain bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 France bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Italy bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Norway bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Denmark bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Sweden bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Japan bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 China bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 India bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Australia bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 South Korea bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Thailand bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Brazil bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Argentina bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 MEA bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 South Africa bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Saudi Arabia bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 UAE bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Kuwait bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key company categorization
  • Fig. 77 Heat map analysis 2024
目次
Product Code: 978-1-68038-980-7

Bioprosthetics Market Growth & Trends:

The global bioprosthetics market size is expected to reach USD 7.64 billion by 2030, registering a CAGR of 4.40% from 2025 to 2030, according to a new report by Grand View Research, Inc. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.

Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.

The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.

Bioprosthetics Market Report Highlights:

  • The allograft segment is expected to exhibit growth at a significant CAGR during the forecast period. This is a consequence of the following associated advantages such as reduced surgical time, smaller incisions, greater physiological acceptability, availability of larger grafts, and a safer alternative to procedures that employ synthetic grafts as they pose a high risk of complications under anesthesia
  • The plastic surgery and wound healing segment is anticipated to witness an exponential CAGR of over 9.6% in the application segment over the forecast period. This substantial share can be attributed to the increasing number of soft tissue repair procedures, such as in hernia and abdominal wall reconstruction
  • Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments
  • In 2023, Europe dominated the overall bioprosthetics market. Moreover, the subsequent changes in the demographic trends, such as the frequent product approvals, increasing geriatric population base, lifestyle-associated changes, and the high awareness levels pertaining to the availability of bioprosthetics solutions are anticipated to drive the market growth in this region
  • For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe
  • Some leading players in this industry include Edwards Lifesciences Corporation, St.Jude Medical, Inc., Sorin Group, CryoLife, Inc., Braile Biomedica, Inc., and Medtronic Plc; these players are increasingly involved in adopting collaborative strategies and launching frequent product approvals to facilitate business expansion

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioprosthetics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioprosthetics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioprosthetics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioprosthetics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Allograft
    • 4.3.1. Allograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Xenograft
    • 4.4.1. Xenograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioprosthetics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioprosthetics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular
    • 5.3.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Plastic Surgery & Wound Healing
    • 5.4.1. Plastic Surgery & Wound Healing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million

Chapter 6. Bioprosthetics Market: Regional Estimates & Trend Analysis

  • 6.1. Bioprosthetics Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. LeMaitre Vascular, Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Braile Biomedica
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Labcor Laboratorios Ltda
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Rua Life Sciences Plc (Aortech International Plc.)
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. LivaNova PLC (Sorin Group)
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Organogenesis Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Humacyte Global, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Johnson & Johnson (Ethicon, Inc.)
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Artivion, Inc. (CryoLife, Inc.)
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. Abbott (St. Jude Medical, Inc.)
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Edwards Lifesciences Corporation.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. JenaValve
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives